Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment

NCT06805994 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

175

Enrollment

OTHER

Sponsor class

Conditions

Staphylococcal Aureus Infection
Microbial Colonization
Pediatric Infection
S. Aureus Colonization
Microbial Transplant

Interventions

BIOLOGICAL: Nasal Microbiota Transplant (NMT)
BIOLOGICAL: Placebo

Sponsor

Johns Hopkins University